Intellia Therapeutics, Inc. (NTLA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.07
Day's range
$14.15

Intellia Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARK INVESTMENT MANAGEMENT LLC 05/12/2026 14.51 M $186.01 M   2.13% 13.39%
BLACKROCK, INC. 05/13/2026 12.16 M $155.84 M   18.28% 11.22%
STATE STREET CORP 05/15/2026 6.92 M $88.75 M   7.85% 6.39%
05/08/2026 6.22 M $79.78 M   100.00% 5.74%
D. E. SHAW & CO., INC. 05/15/2026 5.73 M $73.44 M   7.45% 5.29%
05/15/2026 5.08 M $65.18 M   100.00% 4.69%
TWO SIGMA INVESTMENTS, LP 05/15/2026 4.71 M $60.33 M   74.37% 4.34%
REGENERON PHARMACEUTICALS, INC. 05/08/2026 3.70 M $47.47 M   0.00% 3.42%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.85 M $36.56 M   5.76% 2.63%
UBS GROUP AG 05/05/2026 2.69 M $34.48 M   212.89% 2.48%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 2.32 M $29.71 M   19.99% 2.14%
MORGAN STANLEY 05/15/2026 2.08 M $26.68 M   -10.59% 1.92%
FMR LLC 05/15/2026 2.07 M $26.50 M   17.46% 1.91%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/30/2026 1.97 M $25.29 M   -10.01% 1.82%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 05/07/2026 1.97 M $25.27 M   -10.01% 1.82%
CONTRARIUS GROUP HOLDINGS LTD 05/11/2026 1.91 M $24.51 M   167.58% 1.76%
JUPITER ASSET MANAGEMENT LTD 05/12/2026 1.78 M $22.83 M   71.60% 1.64%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 1.67 M $21.38 M   138.33% 1.54%
GOLDMAN SACHS GROUP INC 05/15/2026 1.63 M $20.87 M   11.86% 1.50%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2026 1.61 M $20.66 M   -7.25% 1.49%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 1.40 M $17.91 M   100.00% 1.29%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.38 M $17.71 M   11.21% 1.27%
STIFEL FINANCIAL CORP 05/12/2026 1.01 M $12.98 M   8.73% 0.93%
NORTHERN TRUST CORP 05/14/2026 966.29 K $12.39 M   10.74% 0.89%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 941.29 K $12.07 M   -0.47% 0.87%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 748.64 K $9.60 M   188.26% 0.69%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 748.10 K $9.59 M   100.00% 0.69%
CAPITAL FUND MANAGEMENT S.A. 05/14/2026 730.12 K $9.36 M   278.25% 0.67%
IQ EQ FUND MANAGEMENT (IRELAND) LTD 05/11/2026 724.29 K $9.29 M   -0.98% 0.67%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 630.53 K $8.08 M   101.00% 0.58%
MAREX GROUP PLC 05/13/2026 623.60 K $7.99 M   0.00% 0.58%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 579.43 K $7.43 M   -2.00% 0.53%
RAYMOND JAMES FINANCIAL INC 05/14/2026 576.93 K $7.40 M   43.64% 0.53%
UBS GROUP AG 05/05/2026 568.77 K $7.29 M   50.40% 0.52%
JANE STREET GROUP, LLC 05/12/2026 551.40 K $7.07 M   58.18% 0.51%
VESTMARK ADVISORY SOLUTIONS, INC. 05/15/2026 550.14 K $7.05 M   23.93% 0.51%
JPMORGAN CHASE & CO 05/13/2026 548.49 K $6.39 M   -26.25% 0.51%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 521.47 K $6.69 M   -14.33% 0.48%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 513.40 K $6.58 M   -11.47% 0.47%
HRT FINANCIAL LP 05/14/2026 502.34 K $6.44 M   -34.33% 0.46%
CAPTION MANAGEMENT, LLC 05/15/2026 479.90 K $6.15 M   966.44% 0.44%
ROYAL BANK OF CANADA 05/15/2026 465.50 K $5.97 M   1,082.13% 0.43%
CITADEL ADVISORS LLC 05/15/2026 458.24 K $5.87 M   -51.78% 0.42%
BIRCHVIEW CAPITAL, LP 05/15/2026 445.40 K $5.71 M   41.22% 0.41%
INVESCO LTD. 05/12/2026 434.75 K $5.57 M   0.34% 0.40%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 05/12/2026 429.54 K $5.51 M   -25.76% 0.40%
JANE STREET GROUP, LLC 05/12/2026 414.70 K $5.32 M   87.90% 0.38%
CITADEL ADVISORS LLC 05/15/2026 410.60 K $5.26 M   -45.59% 0.38%
JANE STREET GROUP, LLC 05/12/2026 384.96 K $4.94 M   15.79% 0.36%
FEDERATED HERMES, INC. 05/11/2026 368.62 K $4.73 M   3.85% 0.34%

Intellia Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 429 institutional investors and hedge funds held shares of Intellia Therapeutics Inc. The most heavily invested institutionals were:

ARK Investment Management LLC: 14.51 M

BlackRock, Inc.: 12.16 M

STATE STREET CORP: 6.92 M

D. E. Shaw & Co., Inc.: 5.73 M

TWO SIGMA INVESTMENTS, LP: 4.71 M

REGENERON PHARMACEUTICALS, INC.: 3.7 M

101.89% of Intellia Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 131.97 M shares in the last 24 months. This purchase volume represents approximately $1.83 B in transactions.